| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stomach Neoplasms | 38 | 2022 | 1332 | 7.800 |
Why?
|
| Esophageal Neoplasms | 31 | 2023 | 1585 | 4.630 |
Why?
|
| Esophagogastric Junction | 17 | 2023 | 313 | 3.590 |
Why?
|
| Cardia | 9 | 2020 | 57 | 3.350 |
Why?
|
| Barrett Esophagus | 25 | 2023 | 494 | 3.080 |
Why?
|
| Adenocarcinoma | 30 | 2023 | 6364 | 2.360 |
Why?
|
| Gastric Mucosa | 10 | 2021 | 599 | 1.980 |
Why?
|
| Lymphatic Metastasis | 17 | 2023 | 2924 | 1.930 |
Why?
|
| Carcinoma | 9 | 2020 | 2375 | 1.450 |
Why?
|
| China | 22 | 2019 | 2245 | 1.320 |
Why?
|
| Stomach | 5 | 2018 | 697 | 1.180 |
Why?
|
| Gastrectomy | 14 | 2022 | 663 | 1.030 |
Why?
|
| Lymphangioma | 2 | 2019 | 65 | 1.020 |
Why?
|
| Brunner Glands | 1 | 2023 | 11 | 0.940 |
Why?
|
| Esophagus | 8 | 2015 | 1019 | 0.900 |
Why?
|
| Duodenal Neoplasms | 1 | 2023 | 106 | 0.890 |
Why?
|
| Neoplasm Staging | 23 | 2018 | 11031 | 0.870 |
Why?
|
| Adenocarcinoma, Papillary | 2 | 2022 | 84 | 0.860 |
Why?
|
| Bile Duct Neoplasms | 2 | 2018 | 567 | 0.830 |
Why?
|
| Cholangiocarcinoma | 2 | 2018 | 516 | 0.830 |
Why?
|
| Heart Neoplasms | 2 | 2021 | 374 | 0.730 |
Why?
|
| Endoscopy, Gastrointestinal | 8 | 2016 | 868 | 0.700 |
Why?
|
| Pyloric Antrum | 2 | 2018 | 69 | 0.670 |
Why?
|
| Receptors, G-Protein-Coupled | 5 | 2014 | 1222 | 0.660 |
Why?
|
| Tomography, Optical Coherence | 14 | 2020 | 2657 | 0.650 |
Why?
|
| Gastritis | 3 | 2015 | 196 | 0.630 |
Why?
|
| Genes, p16 | 1 | 2018 | 157 | 0.610 |
Why?
|
| Adenoma | 5 | 2023 | 2174 | 0.600 |
Why?
|
| Neoplasm Invasiveness | 10 | 2022 | 3616 | 0.600 |
Why?
|
| Carcinosarcoma | 1 | 2018 | 108 | 0.590 |
Why?
|
| Pancreas | 2 | 2016 | 1687 | 0.590 |
Why?
|
| Neoplasms, Complex and Mixed | 1 | 2017 | 31 | 0.580 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2018 | 188 | 0.580 |
Why?
|
| Choristoma | 2 | 2016 | 214 | 0.580 |
Why?
|
| Esophageal Diseases | 3 | 2012 | 167 | 0.570 |
Why?
|
| Gene Amplification | 2 | 2018 | 1063 | 0.570 |
Why?
|
| Immunohistochemistry | 19 | 2018 | 11366 | 0.560 |
Why?
|
| Pancreatitis | 1 | 2023 | 1092 | 0.550 |
Why?
|
| Esophagoscopy | 10 | 2019 | 390 | 0.530 |
Why?
|
| Receptor, erbB-2 | 3 | 2014 | 2417 | 0.520 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2018 | 2649 | 0.500 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 705 | 0.500 |
Why?
|
| Digestive System Diseases | 1 | 2016 | 147 | 0.490 |
Why?
|
| Cadherins | 2 | 2016 | 907 | 0.490 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2013 | 332 | 0.490 |
Why?
|
| Metaplasia | 7 | 2020 | 313 | 0.490 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2020 | 570 | 0.480 |
Why?
|
| Gastroscopy | 4 | 2016 | 207 | 0.480 |
Why?
|
| Survival Rate | 17 | 2023 | 12788 | 0.480 |
Why?
|
| Helicobacter Infections | 5 | 2020 | 387 | 0.460 |
Why?
|
| Aged | 52 | 2023 | 163288 | 0.450 |
Why?
|
| Middle Aged | 58 | 2023 | 213390 | 0.450 |
Why?
|
| Kaplan-Meier Estimate | 9 | 2017 | 6539 | 0.440 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 874 | 0.440 |
Why?
|
| Genomic Instability | 1 | 2017 | 695 | 0.440 |
Why?
|
| Aged, 80 and over | 27 | 2020 | 57776 | 0.430 |
Why?
|
| Biopsy | 10 | 2020 | 6755 | 0.420 |
Why?
|
| Prognosis | 18 | 2023 | 29060 | 0.420 |
Why?
|
| Neoplastic Stem Cells | 2 | 2017 | 1376 | 0.420 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 602 | 0.420 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2015 | 503 | 0.410 |
Why?
|
| Pathology, Clinical | 1 | 2015 | 368 | 0.400 |
Why?
|
| Male | 79 | 2023 | 350115 | 0.400 |
Why?
|
| Genetic Markers | 1 | 2018 | 2634 | 0.400 |
Why?
|
| Medulla Oblongata | 6 | 1997 | 243 | 0.390 |
Why?
|
| Sirtuin 1 | 4 | 2013 | 246 | 0.390 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2018 | 808 | 0.380 |
Why?
|
| Carcinoma in Situ | 2 | 2015 | 806 | 0.380 |
Why?
|
| Precancerous Conditions | 7 | 2018 | 975 | 0.370 |
Why?
|
| Humans | 102 | 2023 | 744366 | 0.360 |
Why?
|
| Cell Movement | 2 | 2019 | 5218 | 0.360 |
Why?
|
| Female | 65 | 2023 | 380193 | 0.350 |
Why?
|
| Jejunal Neoplasms | 1 | 2009 | 18 | 0.350 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2008 | 50 | 0.330 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2016 | 2949 | 0.330 |
Why?
|
| Receptors, Estrogen | 1 | 2016 | 2190 | 0.320 |
Why?
|
| Colorectal Neoplasms | 5 | 2018 | 6773 | 0.310 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3203 | 0.300 |
Why?
|
| Adult | 35 | 2020 | 214052 | 0.300 |
Why?
|
| Polyps | 1 | 2008 | 189 | 0.290 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2013 | 4034 | 0.290 |
Why?
|
| Hamartoma | 1 | 2008 | 238 | 0.290 |
Why?
|
| Retrospective Studies | 21 | 2023 | 77460 | 0.280 |
Why?
|
| Helicobacter pylori | 3 | 2020 | 383 | 0.280 |
Why?
|
| Disease Progression | 8 | 2017 | 13286 | 0.280 |
Why?
|
| Neuroendocrine Tumors | 1 | 2012 | 594 | 0.270 |
Why?
|
| beta Catenin | 2 | 2015 | 1059 | 0.270 |
Why?
|
| Carcinoid Tumor | 3 | 2012 | 235 | 0.270 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2014 | 2943 | 0.260 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 2249 | 0.260 |
Why?
|
| Tumor Burden | 4 | 2019 | 1915 | 0.250 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 2214 | 0.250 |
Why?
|
| Ki-67 Antigen | 4 | 2015 | 644 | 0.250 |
Why?
|
| Lymph Node Excision | 5 | 2022 | 1262 | 0.230 |
Why?
|
| Respiratory Mechanics | 3 | 1997 | 686 | 0.220 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2018 | 713 | 0.220 |
Why?
|
| Duodenum | 2 | 2023 | 484 | 0.200 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2015 | 434 | 0.200 |
Why?
|
| Gastroesophageal Reflux | 2 | 2023 | 782 | 0.200 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4253 | 0.200 |
Why?
|
| Proportional Hazards Models | 6 | 2017 | 12356 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 8432 | 0.180 |
Why?
|
| Phrenic Nerve | 6 | 1997 | 79 | 0.180 |
Why?
|
| Age Distribution | 2 | 2016 | 2902 | 0.170 |
Why?
|
| Risk Factors | 11 | 2019 | 72296 | 0.170 |
Why?
|
| Capsule Endoscopy | 1 | 2020 | 125 | 0.170 |
Why?
|
| Lymph Nodes | 4 | 2017 | 3476 | 0.170 |
Why?
|
| Gastric Fundus | 1 | 2018 | 39 | 0.170 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 2428 | 0.160 |
Why?
|
| Esophagectomy | 2 | 2020 | 447 | 0.160 |
Why?
|
| World Health Organization | 2 | 2015 | 1318 | 0.160 |
Why?
|
| Ploidies | 2 | 2008 | 281 | 0.150 |
Why?
|
| Goblet Cells | 1 | 2020 | 287 | 0.150 |
Why?
|
| Predictive Value of Tests | 5 | 2017 | 15078 | 0.150 |
Why?
|
| Colonic Neoplasms | 3 | 2014 | 2542 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2014 | 4042 | 0.150 |
Why?
|
| Cerebellum | 3 | 1993 | 1488 | 0.140 |
Why?
|
| Respiration | 5 | 1996 | 1653 | 0.140 |
Why?
|
| Sex Factors | 3 | 2016 | 10400 | 0.140 |
Why?
|
| Treatment Outcome | 10 | 2023 | 63107 | 0.140 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 651 | 0.140 |
Why?
|
| Mucous Membrane | 3 | 2019 | 673 | 0.140 |
Why?
|
| Cystadenoma | 1 | 2015 | 84 | 0.130 |
Why?
|
| Necrosis | 2 | 2018 | 1643 | 0.130 |
Why?
|
| Intestinal Mucosa | 3 | 2013 | 3037 | 0.130 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2016 | 140 | 0.130 |
Why?
|
| Hazardous Substances | 1 | 2016 | 149 | 0.130 |
Why?
|
| Quinolinic Acid | 1 | 1995 | 67 | 0.130 |
Why?
|
| Oxyphil Cells | 1 | 2015 | 57 | 0.130 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 1041 | 0.130 |
Why?
|
| Endoscopy, Digestive System | 3 | 2012 | 345 | 0.130 |
Why?
|
| Choledocholithiasis | 1 | 2015 | 48 | 0.120 |
Why?
|
| Hepatitis B virus | 1 | 2018 | 513 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20130 | 0.120 |
Why?
|
| Cats | 7 | 1994 | 1000 | 0.120 |
Why?
|
| Chemokine CCL20 | 1 | 2014 | 65 | 0.120 |
Why?
|
| Granular Cell Tumor | 1 | 2014 | 51 | 0.120 |
Why?
|
| Signal Transduction | 1 | 2017 | 23404 | 0.120 |
Why?
|
| Receptors, CCR6 | 1 | 2014 | 81 | 0.120 |
Why?
|
| Perioperative Period | 1 | 2015 | 256 | 0.120 |
Why?
|
| Huntington Disease | 3 | 1995 | 1124 | 0.120 |
Why?
|
| Receptors, Muscarinic | 1 | 1994 | 156 | 0.120 |
Why?
|
| Prebiotics | 1 | 2013 | 44 | 0.120 |
Why?
|
| Genes, APC | 1 | 2014 | 159 | 0.120 |
Why?
|
| CA-125 Antigen | 1 | 2016 | 286 | 0.120 |
Why?
|
| Neostriatum | 1 | 1995 | 250 | 0.120 |
Why?
|
| Incidence | 4 | 2016 | 20952 | 0.110 |
Why?
|
| Hepatectomy | 1 | 2017 | 550 | 0.110 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2019 | 643 | 0.110 |
Why?
|
| Deglutition Disorders | 1 | 2019 | 606 | 0.110 |
Why?
|
| Dilatation, Pathologic | 1 | 2015 | 520 | 0.110 |
Why?
|
| Dissent and Disputes | 1 | 2014 | 141 | 0.110 |
Why?
|
| Kainic Acid | 5 | 1997 | 199 | 0.110 |
Why?
|
| Preoperative Period | 1 | 2015 | 550 | 0.110 |
Why?
|
| Dissection | 1 | 2015 | 295 | 0.110 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2015 | 230 | 0.110 |
Why?
|
| Laryngeal Nerves | 2 | 1989 | 56 | 0.110 |
Why?
|
| Microvessels | 1 | 2017 | 544 | 0.110 |
Why?
|
| Angiography | 2 | 2017 | 1639 | 0.110 |
Why?
|
| Spectrum Analysis | 1 | 2014 | 454 | 0.110 |
Why?
|
| Gallstones | 1 | 2015 | 286 | 0.100 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2013 | 147 | 0.100 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 1420 | 0.100 |
Why?
|
| Aging | 2 | 2011 | 8664 | 0.100 |
Why?
|
| Biotin | 2 | 1997 | 254 | 0.100 |
Why?
|
| Lac Operon | 1 | 1992 | 238 | 0.100 |
Why?
|
| Receptors, Dopamine | 1 | 1992 | 295 | 0.100 |
Why?
|
| Diagnostic Errors | 2 | 2016 | 1257 | 0.100 |
Why?
|
| Time Factors | 4 | 2019 | 40075 | 0.100 |
Why?
|
| Vestibular Nuclei | 1 | 1991 | 22 | 0.100 |
Why?
|
| Intestinal Neoplasms | 1 | 2014 | 319 | 0.100 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2017 | 871 | 0.100 |
Why?
|
| Risk Assessment | 4 | 2019 | 23336 | 0.100 |
Why?
|
| Young Adult | 8 | 2016 | 56429 | 0.100 |
Why?
|
| Liposarcoma | 1 | 2014 | 333 | 0.100 |
Why?
|
| Recurrent Laryngeal Nerve | 2 | 1989 | 139 | 0.100 |
Why?
|
| Pancreatectomy | 1 | 2016 | 804 | 0.100 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2015 | 604 | 0.100 |
Why?
|
| Endosonography | 1 | 2015 | 610 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1184 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2016 | 2297 | 0.090 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2016 | 576 | 0.090 |
Why?
|
| Alu Elements | 1 | 2011 | 119 | 0.090 |
Why?
|
| Rad51 Recombinase | 1 | 2011 | 189 | 0.090 |
Why?
|
| Demography | 1 | 2015 | 1655 | 0.090 |
Why?
|
| Postoperative Period | 1 | 2015 | 1842 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12244 | 0.090 |
Why?
|
| Probiotics | 1 | 2013 | 351 | 0.090 |
Why?
|
| Microcirculation | 1 | 2014 | 1287 | 0.090 |
Why?
|
| Age of Onset | 1 | 2016 | 3270 | 0.090 |
Why?
|
| Age Factors | 4 | 2016 | 18373 | 0.090 |
Why?
|
| Colonic Polyps | 1 | 2014 | 542 | 0.090 |
Why?
|
| Triazoles | 1 | 2015 | 908 | 0.090 |
Why?
|
| Asia | 1 | 2011 | 609 | 0.090 |
Why?
|
| Retinal Degeneration | 1 | 2013 | 415 | 0.080 |
Why?
|
| Cyclophosphamide | 1 | 2015 | 2242 | 0.080 |
Why?
|
| Stem Cells | 2 | 2015 | 3567 | 0.080 |
Why?
|
| Colonoscopy | 2 | 2014 | 1367 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2015 | 1487 | 0.080 |
Why?
|
| Lung Volume Measurements | 1 | 1989 | 378 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 4185 | 0.080 |
Why?
|
| Early Detection of Cancer | 3 | 2017 | 3086 | 0.080 |
Why?
|
| Simplexvirus | 1 | 1992 | 803 | 0.080 |
Why?
|
| Eyelid Neoplasms | 1 | 2009 | 94 | 0.080 |
Why?
|
| Endoscopy | 2 | 2015 | 1787 | 0.080 |
Why?
|
| Cross-Cultural Comparison | 1 | 2011 | 651 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 2 | 2016 | 5263 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 9240 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2019 | 2150 | 0.080 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2011 | 640 | 0.070 |
Why?
|
| North America | 1 | 2011 | 1249 | 0.070 |
Why?
|
| Diagnosis, Differential | 4 | 2016 | 12961 | 0.070 |
Why?
|
| Catheter Ablation | 4 | 2017 | 2758 | 0.070 |
Why?
|
| Decerebrate State | 4 | 1997 | 43 | 0.070 |
Why?
|
| Autopsy | 1 | 2011 | 1020 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2012 | 689 | 0.070 |
Why?
|
| Antigens, CD34 | 1 | 2009 | 659 | 0.070 |
Why?
|
| DNA | 2 | 2013 | 7294 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10483 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 3508 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4851 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2019 | 7730 | 0.070 |
Why?
|
| Colectomy | 1 | 2011 | 680 | 0.070 |
Why?
|
| Fluorouracil | 1 | 2011 | 1619 | 0.070 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 1586 | 0.070 |
Why?
|
| Facial Nerve | 1 | 1988 | 271 | 0.070 |
Why?
|
| Corpus Striatum | 1 | 1992 | 1221 | 0.070 |
Why?
|
| Health | 1 | 2008 | 394 | 0.070 |
Why?
|
| Adolescent | 6 | 2016 | 85779 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 17446 | 0.060 |
Why?
|
| Rats | 9 | 2013 | 24252 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2013 | 8300 | 0.060 |
Why?
|
| Stem Cell Transplantation | 2 | 2006 | 1620 | 0.060 |
Why?
|
| Vagotomy | 2 | 1997 | 83 | 0.060 |
Why?
|
| Europe | 1 | 2011 | 3338 | 0.060 |
Why?
|
| Hypercapnia | 4 | 1996 | 260 | 0.060 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2010 | 990 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 1782 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2013 | 4222 | 0.060 |
Why?
|
| SEER Program | 3 | 2015 | 1507 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 1970 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2010 | 814 | 0.060 |
Why?
|
| Microscopy | 1 | 2009 | 902 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2016 | 2494 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 16690 | 0.050 |
Why?
|
| Coloring Agents | 2 | 2019 | 566 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3511 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 1995 | 4463 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 2104 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2009 | 13104 | 0.050 |
Why?
|
| Bacteria | 1 | 2013 | 2115 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 2917 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4153 | 0.050 |
Why?
|
| Animals | 21 | 2018 | 168768 | 0.050 |
Why?
|
| Massachusetts | 2 | 2016 | 8662 | 0.050 |
Why?
|
| Spinal Nerves | 2 | 1993 | 86 | 0.050 |
Why?
|
| Neurons | 5 | 1997 | 9340 | 0.050 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2002 | 139 | 0.050 |
Why?
|
| DNA, Neoplasm | 1 | 2007 | 1758 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11486 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 1997 | 2726 | 0.050 |
Why?
|
| Disease Management | 1 | 2011 | 2460 | 0.050 |
Why?
|
| Colon | 1 | 2009 | 1772 | 0.050 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 2186 | 0.050 |
Why?
|
| Tissue Array Analysis | 2 | 2013 | 553 | 0.050 |
Why?
|
| Heart | 2 | 2006 | 4464 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 1879 | 0.050 |
Why?
|
| Phenotype | 1 | 2018 | 16367 | 0.050 |
Why?
|
| Iodides | 1 | 2019 | 41 | 0.050 |
Why?
|
| Escherichia coli | 1 | 1992 | 4217 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 5856 | 0.040 |
Why?
|
| Deglutition | 1 | 2020 | 198 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2022 | 581 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 3707 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2011 | 2969 | 0.040 |
Why?
|
| Embryonic Stem Cells | 1 | 2006 | 1295 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 6313 | 0.040 |
Why?
|
| Myocarditis | 1 | 2006 | 771 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 18034 | 0.040 |
Why?
|
| Image Cytometry | 2 | 2008 | 54 | 0.040 |
Why?
|
| Genome, Human | 1 | 2011 | 4420 | 0.040 |
Why?
|
| Epithelium | 2 | 2015 | 1679 | 0.040 |
Why?
|
| Capsule Endoscopes | 1 | 2016 | 16 | 0.040 |
Why?
|
| Reticular Formation | 1 | 1997 | 61 | 0.040 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2017 | 83 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 3554 | 0.040 |
Why?
|
| Equipment Design | 2 | 2020 | 3582 | 0.040 |
Why?
|
| Brain Stem | 3 | 1993 | 846 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 1997 | 146 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2016 | 15297 | 0.040 |
Why?
|
| In Situ Hybridization | 3 | 1995 | 1950 | 0.040 |
Why?
|
| Cytokines | 2 | 2015 | 7323 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2007 | 2921 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 5172 | 0.030 |
Why?
|
| Microinjections | 1 | 1997 | 327 | 0.030 |
Why?
|
| Conscious Sedation | 1 | 2020 | 528 | 0.030 |
Why?
|
| Keratin-7 | 1 | 2015 | 57 | 0.030 |
Why?
|
| Keratin-5 | 1 | 2015 | 46 | 0.030 |
Why?
|
| Muramidase | 1 | 2015 | 174 | 0.030 |
Why?
|
| Prevalence | 1 | 2012 | 15221 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 14723 | 0.030 |
Why?
|
| Efferent Pathways | 2 | 1993 | 167 | 0.030 |
Why?
|
| Histocytochemistry | 2 | 1997 | 719 | 0.030 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 8642 | 0.030 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1994 | 19 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 146 | 0.030 |
Why?
|
| Hyperoxia | 1 | 1997 | 262 | 0.030 |
Why?
|
| Mutation | 2 | 2017 | 29786 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 2016 | 39052 | 0.030 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 172 | 0.030 |
Why?
|
| Brain | 4 | 1995 | 26388 | 0.030 |
Why?
|
| Length of Stay | 2 | 2019 | 6311 | 0.030 |
Why?
|
| Pirenzepine | 1 | 1994 | 115 | 0.030 |
Why?
|
| Autoradiography | 1 | 1994 | 745 | 0.030 |
Why?
|
| Benzoquinones | 1 | 2013 | 201 | 0.030 |
Why?
|
| Adamantane | 1 | 1994 | 173 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2013 | 387 | 0.030 |
Why?
|
| Neurites | 1 | 1995 | 388 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2015 | 494 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 2015 | 395 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 1157 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 2014 | 13035 | 0.030 |
Why?
|
| Photoreceptor Cells | 1 | 2013 | 244 | 0.030 |
Why?
|
| Thalamic Nuclei | 1 | 1992 | 114 | 0.030 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 437 | 0.030 |
Why?
|
| Axonal Transport | 1 | 1992 | 177 | 0.030 |
Why?
|
| Mucins | 1 | 2015 | 564 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2015 | 40559 | 0.030 |
Why?
|
| Lactams, Macrocyclic | 1 | 2013 | 320 | 0.030 |
Why?
|
| Esophagitis | 1 | 2013 | 152 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2011 | 88 | 0.020 |
Why?
|
| Cerebellar Nuclei | 1 | 1991 | 52 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2009 | 3749 | 0.020 |
Why?
|
| Peritoneum | 1 | 2012 | 228 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 1799 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 1992 | 574 | 0.020 |
Why?
|
| Mice | 6 | 2018 | 81201 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5223 | 0.020 |
Why?
|
| Limbic System | 1 | 1992 | 426 | 0.020 |
Why?
|
| Vagus Nerve | 2 | 1989 | 439 | 0.020 |
Why?
|
| United States | 3 | 2015 | 69872 | 0.020 |
Why?
|
| Apoptosis | 2 | 2018 | 9724 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1993 | 1308 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1994 | 2327 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 1992 | 546 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 1992 | 665 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2013 | 530 | 0.020 |
Why?
|
| Glutamates | 1 | 1991 | 398 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2505 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 2 | 2011 | 2727 | 0.020 |
Why?
|
| Chemoreceptor Cells | 1 | 1989 | 86 | 0.020 |
Why?
|
| Proctitis | 1 | 2009 | 40 | 0.020 |
Why?
|
| Motor Neurons | 2 | 1991 | 844 | 0.020 |
Why?
|
| Spleen | 1 | 2015 | 2362 | 0.020 |
Why?
|
| Axons | 2 | 1997 | 1685 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 684 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 1989 | 302 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2015 | 985 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 2646 | 0.020 |
Why?
|
| Endoscopes, Gastrointestinal | 1 | 2007 | 60 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 2126 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1992 | 1063 | 0.020 |
Why?
|
| Fetus | 1 | 1994 | 1880 | 0.020 |
Why?
|
| Pons | 1 | 1988 | 245 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4751 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 5181 | 0.020 |
Why?
|
| Chromosomal Instability | 1 | 2007 | 183 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 2716 | 0.020 |
Why?
|
| Respiratory System | 1 | 1989 | 557 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 19905 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2019 | 12025 | 0.020 |
Why?
|
| Reference Values | 2 | 1995 | 4982 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2850 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2017 | 9849 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2009 | 1851 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2009 | 1536 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 1956 | 0.020 |
Why?
|
| Transfection | 1 | 1992 | 5895 | 0.010 |
Why?
|
| Action Potentials | 1 | 1991 | 1806 | 0.010 |
Why?
|
| Base Sequence | 1 | 1995 | 12797 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 1420 | 0.010 |
Why?
|
| Synapses | 1 | 1992 | 1728 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1988 | 2008 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2009 | 1533 | 0.010 |
Why?
|
| Video Recording | 1 | 2007 | 949 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 7785 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2018 | 53290 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2010 | 8949 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 3505 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 18111 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 4666 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 2002 | 143 | 0.010 |
Why?
|
| Gene Expression | 1 | 1994 | 7798 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8319 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 25039 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 10943 | 0.010 |
Why?
|
| Myocardium | 2 | 2006 | 4772 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2015 | 4232 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2008 | 2266 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2002 | 11718 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21748 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 2088 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13409 | 0.010 |
Why?
|
| Hippocampus | 1 | 1992 | 3675 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 2002 | 414 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2011 | 3743 | 0.010 |
Why?
|
| Intestines | 1 | 2008 | 1924 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 13693 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2014 | 14561 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1995 | 19233 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2008 | 4026 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 1892 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2013 | 9145 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10183 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3690 | 0.010 |
Why?
|
| Diet | 1 | 2015 | 7937 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6386 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2009 | 1911 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 4410 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2002 | 1579 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 21833 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2015 | 12207 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1992 | 5709 | 0.010 |
Why?
|
| Algorithms | 1 | 2014 | 13882 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1994 | 438 | 0.010 |
Why?
|
| Child | 2 | 2011 | 77709 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1997 | 687 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 5882 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2002 | 4196 | 0.010 |
Why?
|
| Graft Survival | 1 | 2002 | 3737 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2002 | 3666 | 0.010 |
Why?
|
| Respiratory Muscles | 1 | 1989 | 139 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2002 | 6442 | 0.000 |
Why?
|
| Paralysis | 1 | 1989 | 247 | 0.000 |
Why?
|
| Radio Waves | 1 | 1989 | 251 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1995 | 6366 | 0.000 |
Why?
|
| Proteins | 1 | 1995 | 6100 | 0.000 |
Why?
|